Brief: Accelerated Bookbuild Offering Of H Shares In Sichuan Kelun-Biotech Biopharmaceutical, Term Sheet Shows
June 4 (Reuters) - ACCELERATED BOOKBUILD OFFERING OF H SHARES IN SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL - TERM SHEET OFFERING SIZE OF US$200 MILLION UNDER ISSUANCE OF H SHARES - TERM SHEET PRICE RANGE SET AT HK$330.20 – 341.00 FOR H SHARES OFFERING - TERM SHEET Further company coverage: 6990.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sichuan Kelun-Biotech Biopharmaceutical
See all newsBrief: Sichuan Kelun-Biotech Biopharmaceutical Subscribes To CZB Structured Deposit VI For RMB500 Mln
Brief: Sichuan Kelun-Biotech Biopharmaceutical Says NMPA Accepts New Indication Application For SAC-TMT
Brief: Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results Of Skb378/Win378 In Asthma, And Initiates Phase 3 Study
China's Sichuan Kelun-Biotech swings to profit in H1 on new product approvals
Brief: Sichuan Kelun-Biotech Biopharmaceutical Posts HY Net Income Attributable Of RMB 388 MLN